Successful BNC101 IND Submission Paves Way for Development of Promising Cancer … – PR Newswire (press release)
|
Successful BNC101 IND Submission Paves Way for Development of Promising Cancer …
PR Newswire (press release) "BNC101 is a new class of anti-cancer agent which targets cancer stem cells. Many current drugs do not specifically target cancer stem cells. We believe that specific drugs, such as BNC101, targeting cancer stem cells will reduce the risk of cancer … |
